Athenex provides fourth quarter and full year 2020 corporate and financial update

Buffalo, n.y., march 01, 2021 (globe newswire) -- athenex, inc., (nasdaq: atnx), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today provided a corporate and financial update for the fourth quarter and full year ended december 31, 2020.
ATNX Ratings Summary
ATNX Quant Ranking